Does wound healing contribute to the eradication of basal cell carcinoma following curettage and electrodessication?

Dermatologic Surgery

Volumn 25, Issue 3, 1999, Pages 183-188

  Nouri, Keyvan ^a   Spencer, James M ^a,b   Taylor, J Richard ^a   Hayag, Marie ^a   DeVoursney, James ^a   Shah, Neha ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASAL CELL CARCINOMA; CANCER SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURETTAGE; DESICCATION; ELECTROSTIMULATION THERAPY; EXCISION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; WOUND HEALING;

CARCINOMA, BASAL CELL; CURETTAGE; HUMANS; SKIN NEOPLASMS; WOUND HEALING;

EID: 0032973991     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4725.1999.08128.x     Document Type: Article

References (20)

1. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994;30:774-8.
2. Edens FL, Bartlow GA, Haghighi P, et al. Effectiveness of curettage and electrodessication in the removal of basal cell carcinoma. J Am Acad Dermatol 1983;9:383-8.
3. Suhge d'Aubermont PC, Bennett RG. Failure of curettage and electrodessication in the removal of basal cell carcinoma. Arch Dermatol 1984;120:1456-60.
4. Salasche SJ. Curettage and electrodessication in the treatment of mid-facial basal cell epithelioma. J Am Acad Dermatol 1983;8:496-503.
5. Davis RE, Spencer JM. Basal and squamous cancer of the facial skin. Current Opinion in Otolaryngology & Head and Neck Surgery 1997;5:86-92.
6. Rowe DE, Carroll RJ, Day CD. Long term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989;15:315-28.
7. Silverman MK, Kopf AW, Grin CM, et al. Recurrence rates of treated basal cell carcinomas. Part 2: curettage-electrodessication. J Dermatol Surg Oncol 1991;17:720-6.
8. Waldorf H, Fewkes J. Wound healing. Adv Dermatol 1995;10:77-97.
9. Spencer JM, Tannenbaum A, Sloan L, Amonette RA. Does inflammation contribute to the eradication of basal cell carcinoma following curettage and electrodessication? Dermatol Surg 1997;23:625-31.
10. Miller SJ. Biology of basal cell carcinoma (part I). J Am Acad Dermatol 1991;24:1-13.
11. DePanfillis G, Colli V, Manfrede G, et al. In situ identification of mononuclear cell infiltrating cutaneous carcinoma: an immunohistochemical study. Acta Dermatovenerol 1979;59:219.
12. Kohchiyama A, Oka D, Ueki H. Expression of human lymphocyte antigen HLA-DR on tumor cells in basal cell carcinoma. J Am Acad Dermatol 1987;113:833-8.
13. Ceballos PI, Barnhill RL. Spontaneous regression cutaneous tumors. Ad Dermatol 1993;8:229-60.
14. Weinstein GD, Frost P. Cell proliferation in human basal cell carcinoma. Cancer Res 1970;30:724-8.
15. Shanoff L, Spira M, Hardy S. Basal cell carcinoma: a statistical approach to rational management. Plast Reconstr Surg 1967;39: 619-24.
16. Hunt MJ, Halliday GM, Weedon D, et al. Regression in basal cell carcinoma: an immunohistochemical analysis. Br J Dermatol 1994; 130:1-8.
17. Levis WR, Kraemer KH, Klingler WG, et al. Topical immunotherapy of basal cell carcinoma with dinitrochlorobenzene. Cancer Res 1973;33:3036-42.
18. Gernstein W. Transplantation of basal cell epithelioma in rabbit. Arch Dermatol 1963;88:834.
19. Lyles TW, Freeman RG, Know JM. Transplantation of basal cell epitheliomas. J Invest Dermatol 1960;34:205-35.
20. Pawowiski A, Haberman HF. Heterotransplantation of human basal cell carcinomas in nude mice. J Invest Dermatol 1979;72:310.